---
nav_exclude: true
title: "Use of COVID-19 Vaccines After Reports of Adverse Events Among Adult Recipients of Janssen (Johnson & Johnson) and mRNA COVID-19 Vaccines (Pfizer-BioNTech and Moderna): Update from the Advisory Committee on Immunization Practices - United States, July 2021"
source_url: "https://tools.cdc.gov/api/embed/downloader/download.asp?m=342778&c=425616"
source_layer: us_cdc_mmwr
category: surveillance_summary
date: 2021-08-12
confidence: 中
mmwr_volume: ""
mmwr_issue: ""
---

## 摘要

ACIP reviewed information on COVID-19 vaccines and concluded that benefits of vaccination outweigh the risks of rare, serious adverse events. 

## 詳細內容

ACIP reviewed information on COVID-19 vaccines and concluded that benefits of vaccination outweigh the risks of rare, serious adverse events. 

## 關鍵發現

(需要透過 WebFetch 補充或人工審核來提取關鍵發現)

---
*萃取時間: 2026-02-05T15:13:40Z*
*資料來源: CDC MMWR*
